Table 3.

All Adverse events in relation to NRS, SF-MNA and MNA

NRS		T1			T2
Risk for malnutrition / no risk		+	–	p	+	–	p
all	Adverse events	53.2% (25)	35.5% (108)		22.6% (7)	9.3% (20)
	No adverse events	46.8% (22)	64.5% (196)	0.02	77.4% (24)	90.7% (195)	0.03
	n total	47	304		31	215
pAP	Adverse events	40.6% (13)	32.7% (82)		13.6% (3)	8.2% (15)
	No adverse events	59.4% (19)	67.3% (169)	0.37	86.4% (19)	91.8% (167)	0.40
	n total	32	251		22	182
rAP	Adverse events	80.0% (12)	49.1% (26)		44.4% (4)	15.2% (5)
	No adverse events	20.0% (3)	50.9% (27)	0.03	55.6% (5)	84.8% (28)	0.06
	n total	15	53		9	33
SF-MNA		T1			T2
Risk for malnutrition / no risk		+	–	p	+	–	p
all	Adverse events	46.4% (39)	35.2% (94)		17.9% (10)	8.9% (17)
	No adverse events	53.6% (45)	64.8% (173)	0.06	82.1% (46)	91.1% (173)	0.06
	n total	84	267		56	190
pAP	Adverse events	39.4% (26)	31.8% (69)		12.8% (6)	7.6% (12)
	No adverse events	60.6% (40)	68.2% (148)	0.25	87.2% (41)	92.3% (145)	0.28
	n total	66	217		47	157
rAP	Adverse events	72.2% (13)	50.0% (25)		44.4% (4)	15.2% (5)
	No adverse events	27.8% (5)	50.0% (25)	0.10	55.6% (5)	84.8% (28)	0.06
	n total	18	50		9	33
MNA		T1			T2
Risk for malnutrition / no risk		+	–	p	+	–	p
all	Adverse events	49.0% (47)	33.7% (86)		17.5% (11)	8.7% (16)
	No adverse events	51.0% (49)	66.3% (169)	0.01	82.5% (52)	91.3% (167)	0.06
	n total	96	255		63	183
pAP	Adverse events	43.2% (33)	29.9% (62)		15.1% (8)	6.6% (10)
	No adverse events	56.8% (43)	70.1% (145)	0.03	8.9% (45)	93.4% (141)	0.06
	n total	76	207		53	141
rAP	Adverse events	70.0% (14)	50.0% (24)		30.0% (3)	18.8% (6)
	No adverse events	30.0% (6)	50.0% (24)	0.13	70.0% (7)	81.2% (26)	0.45
	n total	20	48		10	32